Skip to content

Total debt at other companies

Azenta logo
AzentaAZTA
$55.71M
LeMaitre Vascular logo
LeMaitre VascularLMAT
$20.95M+20.6%
TEC
Bio-TechneTECH
$290.32M-31.4%
CryoPort, Inc. logo
CryoPort, Inc.CYRX
$230.75M+293%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Danaher logo
DanaherDHR

Other financials

Income statement

See full
Revenue$27.5M+24.7%
Gross profit$17.5M+18.2%
Operating income$27.0K+105%
Net income$1.2M+365%
EPS (diluted)$0.02

Balance sheet

See full
Cash & equivalents$22.8M-65.9%
Total equity$372.2M+5.6%
Total assets$400.9M+1.5%

Cash flow

See full
Operating cash flow-$491.0K-128%
CapEx$167.0K-4.6%
Free cash flow-$658.0K-142%

Valuation

See full
Market cap$1.25B+23.8%
Enterprise value$1.24B+28.3%
P/S12.5×-0.4×

Profitability

See full
Gross margin66.9%
Operating margin-16.7%
Net margin-68.7%
FCF margin-15.9%+18.7pp

Returns & leverage

See full
Return on equity-14.5%-4.7pp
Debt / equity0.0×
Current ratio7.3×+2.6×

Where this comes from

Calculated from BioLife Solutions’s reported figures.

Plus components not separately reported this period.

The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioLife Solutions's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioLife Solutions's total debt?
BioLife Solutions (BLFS) reported total debt of $17.36M in Q1 2026.
How has BioLife Solutions's total debt changed year-over-year?
BioLife Solutions's total debt decreased by 35.6% year-over-year, from $26.95M to $17.36M.
What is the long-term trend for BioLife Solutions's total debt?
Over 5 years (2020 to 2025), BioLife Solutions's total debt has grown at a 9.9% compound annual growth rate (CAGR), from $11.15M to $17.9M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.